Assenagon Asset Management S.A. Kura Oncology, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 919,079 shares of KURA stock, worth $5.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

919,079

Previous 919,079 -0.0%

Holding current value

$5.7 Million

Previous $6.07 Million 12.56%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$6.6 - $9.05 $91,707 - $125,749	13,895 Added 1.54%	919,079 $6.07 Million
Q4 2024 Jan 14, 2025	SELL	$8.51 - $19.21 $1.25 Million - $2.82 Million	-146,879 Reduced 13.96%	905,184 $7.88 Million
Q3 2024 Oct 23, 2024	SELL	$18.57 - $23.23 $12.6 Million - $15.8 Million	-679,514 Reduced 39.24%	1,052,063 $20.6 Million
Q2 2024 Jul 18, 2024	BUY	$17.53 - $22.98 $10.1 Million - $13.3 Million	577,732 Added 50.07%	1,731,577 $35.7 Million
Q4 2022 Jan 12, 2023	SELL	$11.23 - $16.9 $29,669 - $44,649	-2,642 Reduced 0.23%	1,153,845 $14.3 Million
Q2 2022 Jul 27, 2022	SELL	$10.71 - $18.33 $5.61 Million - $9.6 Million	-523,709 Reduced 31.17%	1,156,487 $21.2 Million
Q1 2022 Apr 25, 2022	BUY	$11.78 - $16.98 $13.6 Million - $19.7 Million	1,158,356 Added 221.98%	1,680,196 $27 Million
Q4 2021 Feb 01, 2022	SELL	$12.22 - $19.57 $3.87 Million - $6.19 Million	-316,493 Reduced 37.75%	521,840 $7.31 Million
Q3 2021 Oct 19, 2021	BUY	$15.42 - $21.72 $4.69 Million - $6.61 Million	304,254 Added 56.97%	838,333 $15.7 Million
Q2 2021 Jul 15, 2021	BUY	$20.85 - $29.88 $8.67 Million - $12.4 Million	415,879 Added 351.84%	534,079 $11.1 Million
Q4 2020 Feb 01, 2021	SELL	$29.0 - $41.62 $5.95 Million - $8.54 Million	-205,200 Reduced 63.45%	118,200 $3.86 Million
Q3 2020 Oct 07, 2020	BUY	$16.3 - $30.64 $5.27 Million - $9.91 Million	323,400 New	323,400 $9.91 Million
Q3 2018 Oct 29, 2018	SELL	$16.65 - $21.85 $343,023 - $450,153	-20,602 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$14.8 - $18.8 $365,456 - $464,228	-24,693 Reduced 54.52%	20,602 $375,000
Q1 2018 Apr 30, 2018	BUY	$14.5 - $23.4 $656,777 - $1.06 Million	45,295 New	45,295 $849,000

Others Institutions Holding KURA

# of Institutions

189

Shares Held

79.5M

Call Options Held

53.6K

Put Options Held

42.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $415M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Kura Oncology, Inc. Transaction History